Edenred reports EUR 725 million third-quarter revenue: Edenred stock falls 6.72 percent
Published on 10/21/2026 at 11:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSRegulation shapes the earnings path
- Edenred reported EUR 667 million in operating revenue for the third quarter on October 21, 2026.
- Full-year 2026 EBITDA guidance stands at EUR 1.22 billion to EUR 1.26 billion.
- Edenred stock trades at EUR 27.74 at 11:11 a.m. CEST at Lang & Schwarz on October 21, 2026, 6.72 percent below the Xetra close of October 20, 2026.
- UBS raised its target from EUR 19.00 to EUR 28.50 on October 16, 2026.
Edenred (FR0010908533) reported third-quarter total revenue of EUR 725 million on October 21, 2026, versus company-compiled consensus of EUR 709 million, according to Reuters. Operating revenue reached EUR 667 million, while Edenred stock was trading at EUR 27.74 at Lang & Schwarz on October 21, 2026 at 11:11 a.m. CEST, 6.72 percent below the Xetra close of EUR 29.74 on October 20, 2026.
Revenue beats while regulation bites
The headline revenue figure exceeded consensus, but the composition matters. Investing.com reported that operating revenue declined 1.20 percent like-for-like, while regulatory headwinds in Italy and Brazil totaled EUR 54 million.
Mobility provided the clearest counterweight. Reuters reported mobility revenue of EUR 202 million, up 10.70 percent organically, while employee benefits revenue fell 5.90 percent like-for-like to EUR 424 million.
What does the guidance change mean?
Edenred kept its like-for-like 2026 EBITDA decline guidance at 7.00 percent to 10.00 percent, but the absolute range moved down by EUR 10 million to EUR 1.22 billion to EUR 1.26 billion from EUR 1.23 billion to EUR 1.27 billion, according to Investing.com. The company also reaffirmed EBITDA growth of 8.00 percent to 12.00 percent for 2027 and 2028.
Three dates reset the stock story
On July 23, 2026, Edenred had reported EUR 687 million in second-quarter revenue and 10.60 percent revenue growth, according to Ideal Investisseur. On October 16, 2026, UBS raised its Edenred price target from EUR 19.00 to EUR 28.50 while keeping a neutral rating, as reported by Zonebourse. On October 21, 2026, the company reported EUR 725 million in third-quarter total revenue.
The next milestones are Edenred's 2027 and 2028 EBITDA growth targets, both set at 8.00 percent to 12.00 percent, according to Reuters. The figures make the recovery timetable more important than the small third-quarter revenue beat.
Stock faces a regulatory reset
Edenred's share-price reaction puts the regulatory drag ahead of the longer-term growth targets. The stock's 52-week range is EUR 15.23 to EUR 30.85, while market capitalization is EUR 6.5 billion as of October 21, 2026.
Edenred was trading at EUR 27.74 at Lang & Schwarz on October 21, 2026 at 11:11 a.m. CEST, 6.72 percent below the Xetra close of October 20, 2026 at EUR 29.74. The further course of trading is shown by the continuously updated real-time quote of Edenred stock.
Edenred stock facts
- Company: Edenred S.A.
- ISIN: FR0010908533
- Ticker: EDEN.PA
- Primary exchange: Euronext Paris
- Price Lang & Schwarz (as of October 21, 2026, 11:11 a.m. CEST): EUR 27.74
- Change versus Xetra close: minus 6.72 percent
- Xetra close (October 20, 2026): EUR 29.74
- Market capitalization: EUR 6.5 billion (as of October 21, 2026)
- 52-week range: EUR 15.23-EUR 30.85 (as of October 21, 2026)
- Sector / Industry: Information Technology
- Index membership: Euronext 100
Market context: Market report CAC 40.
